Etodolac Extended-Release Tablets and Recombinate recombinant
Determining the interaction of Etodolac Extended-Release Tablets and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etodolac
Brand name: Lodine, Lodine XL
Synonyms: Etodolac
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etodolac Extended-Release Tablets-Recombivax
- Etodolac Extended-Release Tablets-Recombivax HB
- Etodolac Extended-Release Tablets-Recombivax HB Adult
- Etodolac Extended-Release Tablets-Recombivax HB Dialysis Formulation
- Etodolac Extended-Release Tablets-Recombivax HB Pediatric/Adolescent
- Etodolac Extended-Release Tablets-Recort Plus
- Recombinate recombinant-Etomidate
- Recombinate recombinant-Etonogestrel
- Recombinate recombinant-Etonogestrel implant
- Recombinate recombinant-Etonogestrel Intradermal
- Recombinate recombinant-Etopophos
- Recombinate recombinant-Etopophos (Etoposide Injection)